Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Search Results for: Richter's

Richter’s Transformation

Richter’s Transformation Richter’s Transformation First described in 1928, Richter’s Transformation (RT), also called Richter’s Syndrome (RS), occurs when CLL/SLL changes into a related but much more aggressive large cell lymphoma in

He Never Stood a Chance

Margaret wrote this heart-wrenchingly honest and lucid account of her young husband’s passing soon after his chronic lymphocytic leukemia (CLL) went bad and transformed to Richter’s Syndrome or Transformation. Not everyone who develops Richter’s has such a grim story, but sadly too many still do.

ASH 2021: A Phase 1a/b Dose Escalation Study of the Mutation Agnostic BTK/FLT3 Inhibitor Luxeptinib (CG-806) in Patients with Relapsed or Refractory B-Cell Malignancies

Treatments for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (CLL/SLL) are being developed to address refractory cases, in other words, those that no longer respond to current therapies. In this study presented at the American Society of Hematology Annual Meeting and Exhibition (ASH 2021), the results of early (phase 1a/b) trials on Luxeptinib in 23 patients are reviewed.

December 2021 CLL Bloodline

Over the course of a year of monthly meetings, The CLL Bloodline will teach the BASICS needed to understand CLL, bring news, help with the acronym and new vocabulary, and offer

Clinical Trials

Clinical Trials CLL is not a solved problem, but we do have excellent treatments. It was only through clinical trials that the safety and efficacy of existing therapies was proven, and the only

Abbreviations & Acronyms

Abbreviations & Acronyms This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge. It

Didn't find what you where looking for?

Try our advanced search page!